Back to EXEL
Livforsakringsbolaget Skandia, Omsesidigt → EXEL
Livforsakringsbolaget Skandia, Omsesidigt EXEL Position History
Exelixis, Inc. • Healthcare
Quarters held
16
Latest value
$3.5M
Q3 2026
Peak value
$10.6M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $2.8M |
| Q3 2025 | $3.2M |
| Q4 2025 | $4.4M |
| Q4 2025 | $7.2M |
| Q4 2025 | $8M |
| Q1 2026 | $3.6M |
| Q1 2026 | $4.2M |
| Q1 2026 | $7.8M |
| Q2 2026 | $3.1M |
| Q2 2026 | $7.4M |
| Q2 2026 | $9.9M |
| Q2 2026 | $6.1M |
| Q3 2026 | $1.8M |
| Q3 2026 | $6.3M |
| Q3 2026 | $10.6M |
| Q3 2026 | $3.5M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $3.5M | 33.5K | — | — |
| Q3 2026 | $10.6M | 181.3K | — | — |
| Q3 2026 | $6.3M | 37.9K | — | — |
| Q3 2026 | $1.8M | 17.0K | — | — |
| Q2 2026 | $6.1M | 54.2K | — | — |
| Q2 2026 | $9.9M | 181.3K | — | — |
| Q2 2026 | $7.4M | 30.8K | — | — |
| Q2 2026 | $3.1M | 27.5K | — | — |
| Q1 2026 | $7.8M | 181.3K | — | — |
| Q1 2026 | $4.2M | 30.8K | — | — |
| Q1 2026 | $3.6M | 29.1K | — | — |
| Q4 2025 | $8M | 98.7K | — | — |
| Q4 2025 | $7.2M | 164.7K | — | — |
| Q4 2025 | $4.4M | 27.9K | — | — |
| Q3 2025 | $3.2M | 78.1K | — | — |
| Q3 2025 | $2.8M | 24.6K | — | — |
Other funds holding EXEL
$730.6M